{
    "eid": "2-s2.0-85169916784",
    "title": "Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [],
    "authors": [
        "Anchalee Avihingsanon",
        "Hongzhou Lu",
        "Chee Loon Leong",
        "Chien Ching Hung",
        "Ellen Koenig",
        "Sasisopin Kiertiburanakul",
        "Man Po Lee",
        "Khuanchai Supparatpinyo",
        "Fujie Zhang",
        "Sophia Rahman",
        "Michelle L. D'Antoni",
        "Hongyuan Wang",
        "Jason T. Hindman",
        "Hal Martin",
        "Jared M. Baeten",
        "Taisheng Li"
    ],
    "citedby-count": 0,
    "ref-count": 30,
    "ref-list": [
        "Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis",
        "HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment",
        "Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia",
        "HBV/HIV coinfection: impact on the development and clinical treatment of liver diseases",
        "Functional cure of hepatitis B virus infection in individuals with HIV-coinfection: a literature review",
        "Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach",
        "Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services",
        "Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial",
        "Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial",
        "Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B",
        "Tenofovir alafenamide (TAF) clinical pharmacology",
        "Efficacy and safety of switching to a single-tablet regimen of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in HIV-1/hepatitis B-coinfected adults",
        "Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients",
        "Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial",
        "Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial",
        "Brief report: Switching from TDF to TAF in HIV/HBV-coinfected individuals with renal dysfunction-a prospective cohort study",
        "Brief report: effect of antiretroviral switch from tenofovir disoproxil fumarate to tenofovir alafenamide on alanine aminotransferase, lipid profiles, and renal function in HIV/HBV-coinfected individuals in a nationwide Canadian study",
        "Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial",
        "Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials",
        "A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV",
        "Human immunodeficiency virus-1 infection: developing antiretroviral drugs for treatment. Guidance for industry",
        "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance",
        "96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection",
        "Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses",
        "Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis",
        "Obstacles to HBV functional cure: late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection",
        "HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B",
        "HBsAg loss as a treatment endpoint for chronic HBV infection: HBV cure",
        "Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60073434",
            "affilname": "Beijing Ditan Hospital Capital Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073434",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60025530",
            "affilname": "Kuala Lumpur Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025530",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60014234",
            "affilname": "Queen Elizabeth Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014234",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60008706",
            "affilname": "Peking Union Medical College Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008706",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Foster City",
            "@id": "60002909",
            "affilname": "Gilead Sciences Incorporated",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "128470234",
            "affilname": "Shanghai Public Health Clinical Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128470234",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Santo Domingo",
            "@id": "120832939",
            "affilname": "Dominican Institute of Virological Studies",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120832939",
            "affiliation-country": "Dominican Republic"
        }
    ],
    "funding": [
        "Frida Abramov",
        "HBV",
        "John Flaherty",
        "Priyanka Arora",
        "Gilead Sciences"
    ]
}